Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/49454
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2019-12-06T09:05:24Z | - |
dc.date.available | 2019-12-06T09:05:24Z | - |
dc.date.issued | 2013-08 | - |
dc.identifier.citation | Cardona, M., Vella, J., Zarb Adami, M., Azzopardi, L. M., & Serracino-Inglott, A. (2013, August). Cardiovascular medicines: comparative costs and benefits. Poster session presented at the International Pharmaceutical Federation (FIP) World Congress, Dublin, Ireland. | en_GB |
dc.identifier.uri | https://www.um.edu.mt/library/oar/handle/123456789/49454 | - |
dc.description.abstract | A poster presentation regarding Cardiovascular medicines: comparative costs and benefits. Introduction: An increase in global life expectancy and a concomitant shift in population demographics is leading to a greater incidence of non-communicable disease, with cardiovascular(CVA) morbidity being the primary cause of death worldwide. In 2010, 17.3 million deaths and €863 million in healthcare interventions were attributed to CVA disease at a global level. With the same trends exhibiting themselves locally, consideration of the cost of treatment and financial factors was a topical issue. Aims: • Obtain the costs of all cardiovascular drugs found in the local private retail community setting • Analyse the prices of generic and proprietary products and derive a relationship • Observe the effect of a price differential for equivalent products to their sales volume over time. | en_GB |
dc.language.iso | en | en_GB |
dc.publisher | University of Malta. Department of Pharmacy | en_GB |
dc.rights | info:eu-repo/semantics/openAccess | en_GB |
dc.subject | Cardiovascular agents -- Costs -- Malta | en_GB |
dc.subject | Cardiovascular agents -- Economic aspects | en_GB |
dc.subject | Cardiovascular pharmacology | en_GB |
dc.subject | Generic drugs -- Malta | en_GB |
dc.title | Cardiovascular medicines : comparative costs and benefits | en_GB |
dc.type | presentation | en_GB |
dc.rights.holder | The copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder. | en_GB |
dc.description.reviewed | N/A | en_GB |
dc.contributor.creator | Cardona, Mark | - |
dc.contributor.creator | Vella, John | - |
dc.contributor.creator | Zarb Adami, Maurice | - |
dc.contributor.creator | Azzopardi, Lilian M. | - |
dc.contributor.creator | Serracino-Inglott, Anthony | - |
Appears in Collections: | Scholarly Works - FacM&SPha |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Cardiovascular_medicines_comparative_costs_and_benefits_2013.pdf | 410.93 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.